v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Shares Reserved for Future Issuance
The Company has reserved shares of common stock for future issuances as follows:
June 30,December 31,
20262025
Common stock options issued and outstanding2,582,800 3,067,088 
Common stock restricted stock units issued and outstanding7,159,036 6,667,812 
Common stock available for future grants2,439,593 2,204,802 
Common stock available for employee stock purchase plan2,055,542 1,795,996 
Common stock warrants1,500,000 — 
Total15,736,971 13,735,698 
Schedule of Summary of Stock Option Activity
A summary of stock option activity for the six months ended June 30, 2026 is set forth below:
Outstanding Options
SharesWeighted Average Exercise Price
Balance, December 31, 20253,067,088 $15.72 
Options exercised
(26,584)1.51 
Options forfeited and expired
(457,704)11.91 
Balance, June 30, 20262,582,800 $16.54 
Schedule of Options Vested and Expected to Vest
The aggregate intrinsic value of options outstanding as of June 30, 2026 was $0.
June 30, 2026
Number of Shares
Weighted Average Exercise Price
Weighted Average Contractual Life (in Years)
Options vested and exercisable2,357,491$17.14 5.25
Options vested and expected to vest2,582,800$16.54 5.41
Schedule of Activity with Respect to Stock Units A summary of service-based restricted stock units activity for the six months ended June 30, 2026 is set forth below:
SharesWeighted Average Grant Date Fair Value
Outstanding at December 31, 20255,275,312 $5.33 
Granted2,016,980 1.53 
Vested
(1,090,847)6.24 
Forfeited and expired
(417,909)7.21 
Outstanding at June 30, 20265,783,536 $3.69 
Activity with respect to performance-based and market-based restricted stock units was as follows:
SharesWeighted Average Grant Date Fair Value
Outstanding at December 31, 20251,392,500 $2.34 
Granted— — 
Vested— — 
Forfeited and expired(17,000)8.29 
Outstanding at June 30, 20261,375,500 $2.27 
Schedule of Total Stock-Based Compensation
Stock-based compensation expense is reflected in the statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Cost of goods sold$353 $566 $679 $1,109 
Research and development498 769 1,018 1,421 
Selling, general and administrative2,847 4,879 6,137 9,296 
Total$3,698 $6,214 $7,834 $11,826 
The above stock-based compensation expense related to the following equity-based awards (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Stock options and restricted stock units$3,647 $6,123 $7,736 $11,612 
Employee stock purchase plan51 91 98 214 
Total$3,698 $6,214 $7,834 $11,826